Summary of all studies containing PUBCHEM ID 6450015
| Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
|---|---|---|---|---|---|
| PR000625 | ST000899 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Human serum | Homo sapiens | linoleoylcarnitine [Data] |
| PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | ACar 18:2; [Data] |
| PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | ACar 18:2; [Data] |
| PR001022 | ST001515 | A Metabolomic Signature of Glucagon Action in Healthy Individuals with Overweight/Obesity Humans | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001883 | ST003222 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Mammal | Mus musculus | Carnitine C18:2 [Data] |
| PR001700 | ST002736 | Assessing mitochondrial bioenergetics in coronary artery disease: A translational multiomic tissue study in humans (The AMBITION study). | Human | Homo sapiens | carnitine C18:2 [Data] |
| PR001776 | ST002837 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Blood) | Mammal | Mus musculus | linoleoylcarnitine (C18:2)* [Data] |
| PR001776 | ST002836 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Intestine) | Mammal | Mus musculus | linoleoylcarnitine (C18:2)* [Data] |
| PR001139 | ST001796 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mammal | Mus musculus | CAR 18:2 [Data] |
| PR001228 | ST001940 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR000280 | ST000351 | Determining the metabolic profile of wildtype, lrgAB, and atlA mutant Steptococcus mutans grown aerobically and anaerobically | Bacterial cells | Streptococcus mutans | C18:2 [Data] |
| PR001764 | ST002822 | Effect of ERR Agonist in Mouse Heart Post Pressure Overload | Mammal | Mus musculus | linoleoylcarnitine (C18:2)* [Data] |
| PR000547 | ST000758 | Effects of caloric restriction in HCR/LCR rats | Rat | Rattus norvegicus | LINOLEOYLCARNITINE (*) (CAS# 000-00-0); (M+H)+ [Data] |
| PR001180 | ST001870 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Mammal | Rattus norvegicus | linoleoylcarnitine (C18:2)* [Data] |
| PR001762 | ST002820 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001762 | ST002818 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001762 | ST002819 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Human | Homo sapiens | linoleoylcarnitine* [Data] |
| PR001500 | ST002337 | Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Linoleylcarnitine [Data] |
| PR000960 | ST001400 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Human | Homo sapiens | linoleoylcarnitine (C18:2) [Data] |
| PR000960 | ST001516 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Human | Homo sapiens | linoleoylcarnitine (C18:2) [Data] |
| PR000960 | ST001517 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR002165 | ST003520 | Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR002182 | ST003546 | Improved Soil Health and Pasture Phytochemical Richness Underlies Improved Beef Nutrient Density in Southern US Grass-Finished Beef Systems | Mammal | Bos taurus | linoleoylcarnitine (C18:2)* [Data] |
| PR000583 | ST000818 | Integrated nutrigenomic and metabolomic analysis of Africans with variable diet | HUMAN | Homo sapiens | LINOLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR001941 | ST003411 | Intracellular and medium metabolomics for BT-474 cells treated with a range of C75 concentrations for 24 h (C75 MRM included) | Cultured cells | Homo sapiens | Acyl-L-carnitine (18:2) 85 [Data] |
| PR001941 | ST003412 | Intracellular and medium metabolomics for BT-474 cells treated with cerulenin, TVB-2640, and TVB-3166 for 24 h | Cultured cells | Homo sapiens | Acyl-L-carnitine (18:2) 85 [Data] |
| PR001941 | ST003427 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate | Cultured cells | Homo sapiens | Acyl-L-carnitine (18:2) 85 [Data] |
| PR001941 | ST003429 | Intracellular and medium metabolomics of BT-474 cells treated with Fasnall that was manufactured by Enamine | Cultured cells | Homo sapiens | Acyl-L-carnitine (18:2) 85 [Data] |
| PR001941 | ST003430 | Intracellular and medium metabolomics of BT-474 cells treated with GSK2194069 | Cultured cells | Homo sapiens | Acyl-L-carnitine (18:2) 85 [Data] |
| PR001941 | ST003428 | Intracellular and medium metabolomics of BT-474 cells treated with rotenone | Cultured cells | Homo sapiens | Acyl-L-carnitine (18:2) 85 [Data] |
| PR001748 | ST002815 | Investigation of metabolism in hypertrophic cardiomyopathy - HILIC | Mammal | Mus musculus | Linoleoylcarnitine [Data] |
| PR001748 | ST002817 | Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics | Mammal | Mus musculus | Acylcarnitine(18:2) [Data] |
| PR001952 | ST003277 | LC-MS/MS spatial analysis of mouse GI | Mammal | Mus musculus | linoleoylcarnitine (C18:2)* [Data] |
| PR000348 | ST000450 | Metabolic features of chronic fatigue syndrome | Human | Homo sapiens | Linoleylcarnitine [Data] |
| PR001418 | ST002223 | Metabolic profiling of mouse tissues and tissue interstitial fluids | Mammal | Mus musculus | carnitine C18:2 [Data] |
| PR001737 | ST002787 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Human | Homo sapiens | Carnitine C18:2 [Data] |
| PR001118 | ST001745 | Metabolomic profiling of the rat hippocampus across developmental ages and after learning | Mammal | Rattus norvegicus | linoleoylcarnitine (C18:2) [Data] |
| PR001287 | ST002028 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) | Human | Homo sapiens | Linoleoylcarnitine [Data] |
| PR001715 | ST002754 | Metabolomics analysis of maternal obesity model | Mammal | Mus musculus | linoleoylcarnitine (C18:2)* [Data] |
| PR000495 | ST000698 | Metabolomics analysis of Sirt5 knockdown (KD) melanoma | Human | Homo sapiens | LINOLEOYLCARNITINE (*) (CAS# 000-00-0); (M+H)+ [Data] |
| PR000536 | ST000743 | Metabolomics of bariatric weight loss | Human | Homo sapiens | LINOLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000519 | ST000722 | Metabolomics of Diapause in Aedes albopictus | Insect | Aedes albopictus | LINOLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000537 | ST000744 | Metabolomics of intensive weight management clinic (IWMC) weight loss | Human | Homo sapiens | LINOLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR000968 | ST001412 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR000561 | ST000775 | Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study | Human | Homo sapiens | LINOLEOYLCARNITINE (*) (CAS# 000-00-0); (M+H)+ [Data] |
| PR000764 | ST001144 | Microbial depletion and ozone exposure - serum (part II) | Mammal | Mus musculus | linoleoylcarnitine* [Data] |
| PR000541 | ST000751 | Mouse placentas-DEHP exposure | Mouse | Mus musculus | LINOLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR001281 | ST002017 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001281 | ST002018 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001771 | ST002829 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR000902 | ST001325 | Obesity and Poor Diet as Susceptibility Factors for Secondhand Smoke in Childhood Asthma | Human | Homo sapiens | Car(18:2) [Data] |
| PR000840 | ST001253 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Mammal | Mus musculus | linoleoylcarnitine (C18:2) [Data] |
| PR000967 | ST001411 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR000907 | ST002089 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001048 | ST001639 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001048 | ST002088 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001129 | ST001775 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Mammal | Mus musculus | linoleoylcarnitine (C18:2)* [Data] |
| PR001613 | ST002498 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001809 | ST002909 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR000540 | ST000749 | Rat amniotic fluid metabolomics | Rat | Rattus norvegicus | LINOLEOYLCARNITINE (*) (M+H)+ [Data] |
| PR001121 | ST001749 | REACH Metabolomics Study | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001756 | ST002809 | Role of cilia in mitochondrial function | Mammal | Mus musculus;Canis lupus familiaris | linoleoylcarnitine (C18:2)* [Data] |
| PR001072 | ST001669 | Serum metabolome of Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Linoleyl carnitine [Data] |
| PR001451 | ST002269 | Targeted plasma metabolomics in pediatric NAFLD patients | Human | Homo sapiens | AC(18:2) [Data] |
| PR000349 | ST000451 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data | Animal | Mus musculus | Linoleoylcarnitine [Data] |
| PR000349 | ST000452 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Animal | Mus musculus | Linoleoylcarnitine [Data] |
| PR000776 | ST001157 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Mammal | Mus musculus | linoleoylcarnitine (C18:2) [Data] |
| PR000776 | ST001158 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Mammal | Mus musculus | linoleoylcarnitine (C18:2) [Data] |
| PR002020 | ST003254 | The impact of grass- and grain-finishing on metabolomic profiles of North American Black Angus Beef cattle. | Mammal | Bos taurus | linoleoylcarnitine (C18:2)* [Data] |
| PR001282 | ST002019 | TIPs Metabolomics (blood) | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR000651 | ST000946 | Untargeted Metabolomics of T1 Participants | Human | Homo sapiens | LINOLEYL CARNITINE (M+H) [Data] |
| PR001945 | ST003131 | Untargeted Metabolomics on mouse caecal contents | Mammal | Mus musculus | linoleoylcarnitine (C18:2)* [Data] |
| PR001945 | ST003132 | Untargeted Metabolomics on Mouse colonic mucosa | Mammal | Mus musculus | linoleoylcarnitine (C18:2)* [Data] |
| PR001159 | ST001835 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Human | Homo sapiens | linoleoylcarnitine (C18:2)* [Data] |
| PR001180 | ST001869 | WNK463 Inhibition on Right Ventricular metabolomics | Mammal | Rattus norvegicus | linoleoylcarnitine (C18:2)* [Data] |
